GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Election Watch: Will Conservatives and Liberals Move the Meter With Their Stock Picks?
Amgen, Garmin Among Relative Market Leaders Poised to Outperform in Coming Months: BTIG
Market Whales and Their Recent Bets on LLY Options
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
The S&P 500 Typically Outperforms in July, Underperforms August-October - RBC Capital Markets
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier